Moderna, Merck report positive results from cancer-vaccine studywall street journal
This innovation saved lives in the pandemic. Now it is showing strength against cancer.Washington Post
Moderna’s skin cancer immunotherapy benefitsstatnews.com
Moderna, Merck & Co’s cancer vaccine combo holds lead over Keytruda with five-year dataFirstward Pharma
Moderna and Merck announced 5-year data for intisemeron Autogene in combination with KEYTRUDA(R) (pembrolizumab), demonstrating sustained improvement in the primary endpoint of recurrence-free survival in patients with high-risk stage III/IV melanoma.yahoo finance
